Nafcillin
NDC Package 72603-211-10

11-digit billing NDC: 72603021110

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Nafcillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. Marketed by Northstar Rx, Llc, this product is identified by NDC 72603-211 and is authorized under FDA application ANDA090002.

Identification & Billing

NDC Package Code
72603-211-10
Package Description
10 VIAL in 1 BOX / 4 mL in 1 VIAL
Product Code
11-Digit Billing Format
72603021110
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Nafcillin
Dosage Form
-
Usage Information
Nafcillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. Culture and susceptibility tests should be performed initially to determine the causative organism and its susceptibility to the drugĀ (see CLINICAL PHARMACOLOGY - Susceptibility Test Methods).Nafcillin should not be used in infections caused by organisms susceptible to penicillin G. If the susceptibility tests indicate that the infection is due to a methicillin-resistant Staphylococcus sp., therapy with Nafcillin for Injection should be discontinued and alternative therapy provided.To reduce the development of drug-resistant bacteria and maintain the effectiveness of Nafcillin for Injection and other antibacterial drugs, Nafcillin for Injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Regulatory & Marketing

Labeler Name
Northstar Rx, Llc
FDA Application #
ANDA090002
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-01-2024
End Marketing Date
07-01-2024
Listing Expiration
07-01-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (72603-211). Click a package code to view its specific billing and regulatory data.

1 VIAL in 1 BOX / 4 mL in 1 VIAL

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72603-211-10 identifies a specific commercial package of 10 vial in 1 box / 4 ml in 1 vial of Nafcillin, labeled by Northstar Rx, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Northstar Rx, Llc on July 01, 2024. The current certification is valid through July 01, 2024.

How is this Northstar Rx, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72603021110. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72603-211-10
11-Digit CMS (5-4-2)
72603-0211-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.